The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FOLFOX-HAIC/TACE combined with lenvatinib plus tislelizumab as a conversion therapy in initial unresectable hepatocellular carcinoma: A retrospective real-world study.
 
Pengxiang Huang
No Relationships to Disclose
 
Zhiwei Li
No Relationships to Disclose
 
Kun Zhang
No Relationships to Disclose
 
Mingbo Wang
No Relationships to Disclose
 
Zhilong Kang
No Relationships to Disclose
 
Yinan Su
No Relationships to Disclose
 
Wenping Wei
No Relationships to Disclose
 
Yiming Zhang
No Relationships to Disclose
 
Yanzhou Song
No Relationships to Disclose
 
Xin Zhao
No Relationships to Disclose